Patients with advanced solid tumour research hub

An phase I study of BI 765063 (a monoclonal antibody) as single agent and in combination with BI 754091 (a PD-1) to characterize safety, pharmacokinetics, pharmacodynamics and preliminary efficacy in patients with advanced solid tumour

This study is testing new medicines for people with advanced cancers. It's looking to see if these medicines are safe, how they work in the body, and if they might help shrink tumours. It's an early-stage study.